Recombinant Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99

Shelf life

The shelf life of this product is 12 mois
Storage

The storage of this product is at: -20℃
Shipping

The shipping of this product is in: RT
Description

Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

Hemagglutinin-Influenza Virus H1N1 New Caledonia
Short name

Recombinant Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99
Technique

Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. CHI Scientific advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Species

Virus, Influenza, Viruses
Alternative name

Rec. Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99
Alternative technique

rec
Virus

influenza

Name

Hemagglutination Tests
Concept

Scope note: Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)
Tree numbers
- E01.370.225.812.735.050.375
- E05.200.812.735.050.375
- E05.478.594.760.050.375
Qualifiers

ethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data